Bioavailability of Levoketoconazole and Ketoconazole Tablets

Summary

This is a phase 1, randomized, open-label, single-dose, two-period, two-sequence crossover study in healthy male and female subjects to evaluate the relative oral bioavailability of levoketoconazole tablets (the test drug) and ketoconazole tablets (the reference drug product).

Timeline

Start

2019-12-16

Primary completion

2020-01-18

Completion

2020-01-23

Drugs

Indications

No indication recorded.